MiNK Therapeutics, Inc. (INKT) stock
INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$8.84−0.45 (-4.79%)
Close on Nov 18, 2026Market cap $45.11MP/E –Yield –
MiNK Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
MiNK Therapeutics's market cap was $52.11M on Nov 11, 2026, against $42.96M a year earlier. Over the last 5 years it ranged from $25.14M to $107.84M, with a median of $49.56M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $52.11M | +14.3% |
| 2025 | Dec 31, 2025 | $45.57M | +79.3% |
| 2024 | Dec 31, 2024 | $25.42M | -30.5% |
| 2023 | Dec 29, 2023 | $36.56M | -57.7% |
| 2022 | Dec 30, 2022 | $86.41M | -19.9% |
| 2021 | Dec 31, 2021 | $107.84M | – |
See a number that looks wrong?